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Abstract 
Background: In the recent studies, it is suggested that the analysis of transcriptomic change of functional modules 
instead of individual genes would be more effective for system‑wide identification of cellular functions. This could 
also provide a new possibility for the better understanding of difference between human and chimpanzee.
Results: In this study, we analyzed to find molecular characteristics of human brain functions from the difference of 
transcriptome between human and chimpanzee’s brain using the functional module‑centric co‑expression analysis. 
We performed analysis of brain disease association and systems‑level connectivity of species‑specific co‑expressed 
functional modules.
Conclusions: Throughout the analyses, we found human‑specific functional modules and significant overlap 
between their genes in known brain disease genes, suggesting that human brain disorder could be mediated by the 
perturbation of modular activities emerged in human brain specialization. In addition, the human‑specific modules 
having neurobiological functions exhibited higher networking than other functional modules. This finding suggests 
that the expression of neural functions are more connected than other functions, and the resulting high‑order brain 
functions could be identified as a result of consolidated inter‑modular gene activities. Our result also showed that the 
functional module based transcriptome analysis has a potential to expand molecular understanding of high‑order 
complex functions like cognitive abilities and brain disorders.
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Background
To characterize the molecular bases associated with 
human’s remarkably advanced high-order brain functions 
and vulnerability to various brain disorders, a compara-
tive analysis between human and chimpanzee brain tran-
scriptome is considered as an important way [1]. Until 
now, several previous studies compared the transcrip-
tome data of human and chimpanzee brains. Despite 
some successes, little has been understood to account for 
unique features of human brain. In the previous study, 
we showed that a co-expression analysis of functional 
modules has shown increased sensitivity for identifying 
implication of more diverse genes and cellular functions 
that were previously undetected [2]. Recent studies have 
shown the existence of inter-module co-expression net-
works in the human brain, suggesting that systems-level 
relationships might also uniquely constitute human brain 
specificity [3, 4]. However, the implication of functional 
modules and their network properties have not been 
investigated in depth to further extract functional mean-
ings of each module and their interplay with respect to 
human brain specialization. In this study, we analysed to 
find molecular characteristics of human brain functions 
using the human-specific co-expressed functional mod-
ules (HS-COMODs) and the chimpanzee-specific co-
expressed functional modules (CS-COMODs). Our new 
approach using integrated analysis of gene expression 
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data should be an aid in molecular interpretation of other 
complex biological functions too.
Results
Association of HS‑COMODs and brain disorders
We questioned if the human vulnerability to neurode-
generative and psychiatric diseases might be relevant 
to the emergent co-expression of the functional mod-
ules in the human brain. To examine the possibility, we 
compared the HS-COMODs and the CS-COMODs with 
the brain disease modules. Functional modules associ-
ated to neuro/psychological diseases were defined using 
the Fisher’s exact test. The association between the spe-
cies-specific co-expression and brain disease relevance 
of the functional modules was measured using the one-
sided Fisher’s exact test. Our analysis showed that there 
was a statistically significant overlap between the HS-
COMODs and the brain disease modules (Fig.  1). The 
association was observed more strongly with a more 
stringent cut-off used for defining the brain disease 
modules. On the other hand, such association was not 
observed for the CP-COMODs. This data suggests that 
the functional modules that were emergently function-
alized in the human brain might comprise the cellular 
functions sensitive to the genetic perturbations and the 
etiology.
Systems‑level characteristics of HS‑COMODs
To extract the functional meanings, we analysed the 
inter-module co-expression network based on the net-
work connectivity. Since the number of non-overlapping 
functional modules was different for each functional 
module, we normalized the connectivity by dividing by 
the number of non-overlapping HS-COMODs. The HS-
COMODs ranked with the top 10 highest normalized 
connectivity (one-sided Fisher’s exact test, P = 1.52E−03) 
(Fig. 2a) includes pathways for ‘Alzheimer’s disease’, ‘Hun-
tington’s disease’, ‘GRIN1 network’, ‘Integration of energy 
metabolism’, and protein interaction networks pivoted by 
GRIN1 and CDK5, all of which show implication to the 
learning and memory.
There are 25 neurobiological modules in total 248 
non-overlapping HS-COMODs in human-specific 
functional module networks. In top 5 % (13 functional 
modules) HS-COMODs which have highest normal-
ized connectivity, there are 5 neurobiological mod-
ules (one-sided Fisher’s exact test, P  =  4.53E−03). In 
addition, average connectivity score of neurobiologi-
cal modules is 0.308 compare to average connectivity 
of total functional modules and non-neurobiological 
module is 0.246 and 0.239, respectively. These results 
showed that the neurobiological modules had sig-
nificantly higher normalized connectivity than did the 
other modules. In addition, the neurobiological mod-
ules had higher normalized connectivity than the rest, 
particularly in the ‘denser’ network (Fig. 2b). Our data 
suggests the central importance of the neurobiological 
modules, several of which are influential to the high-
order brain functions such as learning or memory, and 
the prevalent functional cooperation of the neurobio-
logical modules with a wide variety of functional mod-
ules in human brain.
We identified the HS-COMODs with the largest nor-
malized connectivity to the neurobiological modules. 
More than half of the HS-COMODs with normalized 
connectivity over than 0.5 were involved in protein 
modification which was overrepresented functional 
category in our results (Table  1); especially, they were 
associated with protein ubiquitination. The concerted 
activity of the individual players such as the E3 ubiq-
uitin ligase and proteasome upon the intra and extra-
cellular stimuli might be crucial, as it has been shown 
that ubiquitin-dependent protein degradation delicately 
controls the life cycle of synaptic proteins for synapse 
regulation and organization, and in turn controls learn-
ing and memory [5, 6]. Implications of ubiquitin sys-
tem have been also reported in previous analyses [7, 8] 
but their unique characteristics in terms of functional 
interplay have not been noted. Several E3s, such as 
AMFR, RNF5, and PARK2, involved in ‘protein ubiq-
uitination’, were shown to specifically target the synap-
tic proteins involved in, for example, the postsynaptic 
density (GO:0014069) and nerve–nerve synaptic trans-
mission (GO:0007270). The other modules, those that 
are highly connected to the neurobiological modules 
such as ‘HIV Infection’, and ‘generation of precursor 
Fig. 1 Overlap between species‑specific modules and brain disease 
modules. The association between the species‑specific co‑expression 
and brain disease relevance of the functional modules was measured 
using the one‑sided Fisher’s exact test
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metabolites and energy’ are also intriguing as it has 
been shown that positive manipulation of the energy 
metabolism may be effective in preventing or revers-
ing cognitive impairments [9] and that the impaired 
immune function in HIV patients may lead to demen-
tia, manifesting the cognitive dysfunction [10]. In sum-
mary, inter-module co-expression analysis among the 
HS-COMODs revealed functional interplay between 
specific and distinct functional modules. The neurobio-
logical HS-COMODs tend to show co-expression with 
other diverse HS-COMODs, implying that the high-
order human brain function such as cognition has been 
emerged by the systemic and parallel change of multiple 
functional modules in a concerted manner.
Discussion
It is important to unravel the molecular mechanisms 
underlying the high-order human brain functions for 
the drug development for the cognition enhancement. 
Despite tremendous researches, only few drugs have 
been approved [11] and the efficacy of those drugs for 
both healthy people and patients with cognitive dys-
functions seems to be modest and even harmful in some 
ways [12]. Recently it has been suggested that targeting 
multiple genes or complementary mechanisms by mul-
tiple drugs would be more desirable approach for the 
improved therapeutics [13, 14]. Moreover, it has been 
shown that evolutionarily emerging genes are likely to be 
the targets of successful drugs [15]. In these regards, this 
Fig. 2 Normalized connectivity of HS‑COMODs. Normalized connectivity of the HS‑COMODs in the inter‑module co‑expression network. a The 
normalized connectivity of HS‑COMODs. The red circle indicates the neurobiological modules. b The normalized connectivity of the neurobiological 
modules and that of the others
Table 1 Top 10 HS-COMODs showing highest connectivity to neurobiological modules
ID Type Name Normalized connectivity
86 Biological process Negative regulation of protein modification process 0.78
250 Pathway HIV Infection 0.67
45 Biological process Generation of precursor metabolites and energy 0.64
200 Hub network RNF5 hub protein network 0.58
226 Pathway Ubiquitin mediated proteolysis (KEGG) 0.56
284 Pathway Protein ubiquitination (UniPathway) 0.56
120 Biological process Protein ubiquitination 0.55
118 Biological process Protein modification by small protein conjugation 0.55
38 Biological process Energy derivation by oxidation of organic compounds 0.54
117 Biological process Proteasomal ubiquitin‑dependent protein catabolic process 0.53
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study might provide insight to the drug development. 
To make it more plausible, it would be further neces-
sary to elucidate the specificity of the transcription fac-
tors or the epigenetic regulators on those key functional 
modules.
Conclusion
We showed the significant overlap between the HS-
COMODs and the brain disease modules, suggesting 
that the emergent functionalization of modular activities 
in human brain might be sensitive to the perturbations. 
In a system-level analysis into the HS-COMODs, it was 
shown that the functional modules show complex inter-
module co-expression in human brain. Of particular 
note, the functional modules implicated to the neurobio-
logical processes showed significantly higher connectivity 
than the others. From this point of view, neurobiological 
modules might have the potential contribution to coop-
erate with a wide variety of functional modules to drive 
cognitive functions at the systems level. Therefore, our 
findings showed that a systems approach adopted in the 
interpretation of transcriptomic change between human 
and chimpanzee brains has a potential to improve our 
molecular understanding of high-order complex func-
tions like cognitive abilities and brain disorders.
Methods
Identification of brain disease modules
The genes associated with human brain disorders was 
compiled from public databases including the OMIM, 
the Genetic Association Database, the Cancer Gene Cen-
sus, the KEGG Disease, and the HugeNavigator. The het-
erogeneous disease names were unified into a controlled 
vocabulary in the Unified Medical Language System 
(UMLS) using MetaMap. The individual diseases con-
verted to the UMLS terms were further categorized into 
the 298 groups of higher classifications available in the 
International Classification of Diseases 10 provided by 
the World Health Organization. Among these 298 disease 
groups, we manually inspected and selected 15 catego-
ries (Table 2) as representative brain disease. To identify 
brain disease module, we used the one-sided Fisher’s 
exact test for the function enrichment analysis. The brain 
disease module was defined to be any functional module 
[16, 17] significantly enriched (FDR adjusted P <0.01) for 
the known genes associated with any brain disease cat-
egory among the 15 selected categories.
Construction of co‑expression network 
and characterization of inter‑modular correlation
We constructed the each species-specific functional 
modules networks. Each of the HS-COMODs and the 
CP-COMODs was represented by the module eigen-
gene which correspond the first principal component 
extracted from the expression levels. We used the Mod-
uleColor and WGCNA R packages to determine the 
module eigengene. Next, the co-expression between 
every pair of module eigengenes was calculated with 
the Pearson’s correlation coefficient and the significance 
of the co-expression was assigned to each pair among 
the 277 distinct HS-COMODs and the 49 distinct CP-
COMODs, respectively [18]. The p values were adjusted 
using the Benjamini and Hochberg method. However, we 
restricted our analysis to pairs of each species-specific 
co-expressed functional modules with no overlapped 
component genes on the microarray data, since the 
overlapping genes significantly affect the co-expression 
measure. Using the significantly coexpressed pairs of HS-
COMODs and CP-COMODs (FDR adjusted P  <0.01), 





Cerebral palsy and other paralytic syndromes
Dementia
Epilepsy
Mental and behavioural disorders due to other psycho‑active substance 
use
Mental and behavioural disorders due to use of alcohol
Mental retardation
Mood (affective) disorders
Nerve, nerve root and plexus disorders
Neurotic, stress‑related and somatoform disorders
Other congenital malformations of the nervous system
Other diseases of the nervous system
Parkinson’s disease
Schizophrenia, schizotypal and delusional disorders
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we produced the two human-specific functional module 
networks, one with higher density (Fig. 3a) and the three 
small and sparse chimpanzee-specific functional module 
networks (Fig. 3b).
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